11319364

Source:http://linkedlifedata.com/resource/pubmed/id/11319364

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003280, umls-concept:C0014733, umls-concept:C0087111, umls-concept:C1522326
pubmed:issue	3 Pt 2
pubmed:dateCreated	2001-4-25
pubmed:abstractText	Low or high dosage heparin adjuvant therapy for Erysipelas (E) has become frequent, especially in France.
pubmed:language	fre
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7702013
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0151-9638
pubmed:author	pubmed-author:Laporte SimitsidisSS, pubmed-author:PerrotJ LJL, pubmed-author:PerrotSS
pubmed:issnType	Print
pubmed:volume	128
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	352-7
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11319364-Anticoagulants, pubmed-meshheading:11319364-Erysipelas, pubmed-meshheading:11319364-Humans
pubmed:year	2001
pubmed:articleTitle	[Is anticoagulant therapy useful when treating erysipelas?].
pubmed:affiliation	Service de Dermatologie, CHU, Saint-Etienne, France.
pubmed:publicationType	Journal Article, English Abstract, Review, Consensus Development Conference